potassium voltage-gated channel subfamily A member 1
Last updated 4 May 2023
Meets Patient’s editorial guidelines
- DownloadDownload
- Share
- Language
- Discussion
- Ask Patient
- Audio Version
- Add to preferred sources on Google
The KCNA1 gene belongs to a large family of genes that provide instructions for making potassium channels. These channels, which transport positively charged potassium atoms (potassium ions) into and out of cells, play a key role in a cell's ability to generate and transmit electrical signals.
Video picks for GenesVideo library
Normal function
The KCNA1 gene belongs to a large family of genes that provide instructions for making potassium channels. These channels, which transport positively charged potassium atoms (potassium ions) into and out of cells, play a key role in a cell's ability to generate and transmit electrical signals.
The KCNA1 gene provides instructions for making one part (the alpha subunit) of a potassium channel called Kv1.1. These channels are found in the brain, where they transport potassium ions into nerve cells (neurons). The flow of certain ions, including potassium, into and out of neurons regulates communication between these cells.
Conditions referring to this gene or chromosome
Other names
AEMK
EA1
HBK1
HUK1
KCNA1_HUMAN
KV1.1
MBK1
MGC126782
MGC138385
MK1
potassium channel, voltage gated shaker related subfamily A, member 1
potassium voltage-gated channel, shaker-related subfamily, member 1 (episodic ataxia with myokymia)
RBK1
voltage-gated potassium channel subunit Kv1.1
Patient picks for Genes

Treatment and medication
Potassium-sparing diuretics
Diuretics are medicines which increase the amount of fluid removed from the body when we pass urine. Potassium-sparing diuretics are one type of diuretic. They are weak diuretics usually prescribed in combination with other types of diuretics. They are used to increase the amount of fluid passed from the body in urine, whilst also preventing too much potassium being lost with it. Side-effects are uncommon when routine low doses are used. Most people are able to take these medicines.
by Dr Doug McKechnie, MRCGP

General health
Medical negligence
Most people receive good care from healthcare professionals. Sometimes, people receive poor care. If this happens, they may wish to make a complaint. If sub-standard care has led to avoidable harm, they may also wish to make a claim for compensation for medical negligence.
by Dr Doug McKechnie, MRCGP

Mental health
Mind and body control - how to channel your ‘internal telekinesis’
The dark nights have arrived, and right on cue, Mike Flanagan has turned his attention to one of Stephen King’s most iconic tales of teenage torment and supernatural terror... Carrie. The story of a schoolgirl with telekinetic powers - the fictional ability to move objects using the mind alone - has gripped our morbid imaginations for decades. Little wonder, then, that this horror classic is getting a new lease of life in a television adaptation. But while we ourselves may not be able to bend spoons or move furniture, we do possess our own real-world form of ‘internal-telekinesis’. Through mental focus and controlled breathing, we can influence our heart rate and help calm an overworked nervous system.
by Hannah Boynton-Forshaw

Drug interactions checker
Can I take Lisinopril and Potassium together?
Taking lisinopril and potassium supplements together can cause the levels of potassium in your blood to become dangerously high (a condition called hyperkalaemia). While your body needs potassium for your heart and muscles to work, too much of it can lead to serious heart rhythm problems or even cause the heart to stop. Symptoms of high potassium can include muscle weakness, tingling sensations, or palpitations, but often there are no symptoms until the level is very high.

Drug interactions checker
Can I take Spironolactone and Potassium together?
Taking spironolactone and potassium supplements together can lead to dangerously high levels of potassium in your blood (a condition called hyperkalaemia). While your body needs potassium for your heart and muscles to work, too much of it can cause serious heart rhythm problems or even cause the heart to stop beating. Symptoms of high potassium can include muscle weakness, tingling sensations, or palpitations, but often there are no symptoms until the level is very high.

Podcasts
Me and myself
In this episode, Clare and Aileen turn their attention to what they describe as the primary relationship - the relationship we have with ourselves - and why it is so often the one we neglect, misunderstand or actively sideline.
by Thomas Andrew Porteus, MBCS
Related patient information and medicines

Patient information leaflet
Angina
Angina is a pain that comes from the heart. It is usually caused by narrowing of the heart's blood vessels - the (coronary) arteries. Usual treatment includes a statin medicine to lower your cholesterol level, low-dose aspirin to help prevent a heart attack, and a beta-blocker medicine to help protect the heart and to prevent angina pains. An.

Patient information leaflet
Acute kidney injury
Acute kidney injury can be a confusing name as it suggests an accident or injury to that part of your body, eg from a fall or trauma. However, acute kidney injury is actually a condition where your kidneys suddenly stop working properly. The earlier acute kidney injury is picked up, and the more carefully you are monitored and treated, the better.

Patient information leaflet
Loop diuretics
Loop diuretics are commonly used in the treatment of heart failure. In this condition, fluid accumulates in your body, due to the heart not pumping blood around the body as well as it normally would. So, you may become breathless (as fluid accumulates in the lungs) and your ankles and legs may swell with extra fluid in the tissues (oedema). Loop.

Patient information leaflet
Potassium-sparing diuretics
They are used to increase the amount of fluid passed from the body in urine, whilst also preventing too much potassium being lost with it. What is potassium. Potassium (chemical symbol K) is a metallic element which is vitally important for our bodies to function. It is one of a group of substances called 'electrolytes' which carry a small.

Patient information leaflet
Can I take Magnesium and Flecainide together?
In some cases, magnesium can actually be helpful for heart rhythm issues, but it must be balanced correctly. Why this happens Both magnesium and flecainide affect the electrical signals and mineral channels (like sodium and potassium) in your heart cells. While they don't usually stop each other from being absorbed, having too much or too little.

Patient information leaflet
Medical negligence
If this happens, they may wish to make a complaint. If sub-standard care has led to avoidable harm, they may also wish to make a claim for compensation for medical negligence. Raising concerns about care Most people, when they become unwell, are treated with very good care and are happy with their treatment. However, sometimes things can go wrong,.
Further reading and references
- potassium voltage-gated channel subfamily A member 1; MedlinePlus, National Library of Medicine.
- Browne DL, Gancher ST, Nutt JG, Brunt ER, Smith EA, Kramer P, Litt M. Episodic ataxia/myokymia syndrome is associated with point mutations in the human potassium channel gene, KCNA1. Nat Genet. 1994 Oct;8(2):136-40. doi: 10.1038/ng1094-136.
- Chen H, von Hehn C, Kaczmarek LK, Ment LR, Pober BR, Hisama FM. Functional analysis of a novel potassium channel (KCNA1) mutation in hereditary myokymia. Neurogenetics. 2007 Apr;8(2):131-5. doi: 10.1007/s10048-006-0071-z. Epub 2006 Nov 29.
- Eunson LH, Rea R, Zuberi SM, Youroukos S, Panayiotopoulos CP, Liguori R, Avoni P, McWilliam RC, Stephenson JB, Hanna MG, Kullmann DM, Spauschus A. Clinical, genetic, and expression studies of mutations in the potassium channel gene KCNA1 reveal new phenotypic variability. Ann Neurol. 2000 Oct;48(4):647-56.
- Jen JC, Graves TD, Hess EJ, Hanna MG, Griggs RC, Baloh RW; CINCH investigators. Primary episodic ataxias: diagnosis, pathogenesis and treatment. Brain. 2007 Oct;130(Pt 10):2484-93. doi: 10.1093/brain/awm126. Epub 2007 Jun 15.
- Maylie B, Bissonnette E, Virk M, Adelman JP, Maylie JG. Episodic ataxia type 1 mutations in the human Kv1.1 potassium channel alter hKvbeta 1-induced N-type inactivation. J Neurosci. 2002 Jun 15;22(12):4786-93. doi: 10.1523/JNEUROSCI.22-12-04786.2002.
- Rajakulendran S, Schorge S, Kullmann DM, Hanna MG. Episodic ataxia type 1: a neuronal potassium channelopathy. Neurotherapeutics. 2007 Apr;4(2):258-66. doi: 10.1016/j.nurt.2007.01.010.
- Rea R, Spauschus A, Eunson LH, Hanna MG, Kullmann DM. Variable K(+) channel subunit dysfunction in inherited mutations of KCNA1. J Physiol. 2002 Jan 1;538(Pt 1):5-23. doi: 10.1113/jphysiol.2001.013242.
- Zerr P, Adelman JP, Maylie J. Episodic ataxia mutations in Kv1.1 alter potassium channel function by dominant negative effects or haploinsufficiency. J Neurosci. 1998 Apr 15;18(8):2842-8. doi: 10.1523/JNEUROSCI.18-08-02842.1998.
Share your thoughts or experiences with others in our patient communities.
Sign up to the Patient newsletter
Your weekly dose of clear, trustworthy health advice - written to help you feel informed, confident and in control.
By subscribing you accept our Privacy Policy. You can unsubscribe at any time. We never sell your data.

